Medicine Man Technologies, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Forrest Hoffmaster
- Full Time Employees
- 729
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 4880 Havana Street Denver CO United States of America 80239
- IPO Date
- Feb 16, 2018
- CIK
- 0001622879
- Website
- schwazze.com
- Similar Companies
- Business
- Medicine Man Technologies, Inc., operating under the trade name Schwazze, is a vertically integrated multi-state cannabis company engaged in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis-related products. Its core product offerings include loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis items. The company operates retail cannabis dispensaries under several brand names, including Star Buds, Emerald Fields, Standing Akimbo, Everest Cannabis Co., and R. Greenleaf. Additionally, Schwazze sells indoor gardening supplies and hydroponics through its online and physical stores. The company conducts its operations primarily in Colorado and New Mexico, managing 63 retail dispensaries, six cultivation facilities, and three manufacturing plants. It segments its business into Retail, Wholesale, and Other segments; the Retail segment oversees cannabis product sales at dispensaries, Wholesale includes cultivation and sale of cannabis and non-cannabis products, and Other encompasses corporate functions, in-store advertising, and vendor promotions. Founded in 2014 and headquartered in Denver, Colorado, Medicine Man Technologies focuses on comprehensive supply chain services including cultivation, processing, extraction, cloning and seed propagation, facility design, feasibility, and dispensary consulting. Recent major company developments include its acquisition by Vireo Growth Inc., announced in late 2025, reflecting a strategic expansion and consolidation within the cannabis sector. This acquisition deal, valued around $62 million, marks a significant operational and ownership change for the company. Prior to this, Schwazze has executed multiple acquisitions of retail and cultivation assets, broadening its footprint and product reach in regulated markets. Medicine Man Technologies targets both medical and adult-use cannabis consumers, positioning itself as a leading cannabis operator with integrated operations across product development, production, and retail distribution. Its business strategy underscores growth through expansion, acquisition, and enhancement of its product portfolio and retail presence in key U.S. cannabis markets. The company continues to leverage its multi-brand retail presence and wholesale capabilities to serve a diverse customer base while pursuing further industry consolidation and operational efficiencies in an evolving cannabis market landscape.
Vireo Growth Inc. Announces Closing of Acquisition of Outstanding Senior Secured Convertible Notes of Schwazze
Schwazze Provides Update on Delayed Filings
Medicine Man Technologies, Inc. (SHWZ) Q2 2024 Earnings Call Transcript
Schwazze Sets Second Quarter 2024 Conference Call for August 13, 2024 at 5:00 p.m. ET
Schwazze Announces Restructuring of February 2025 Debt Obligations
7 Cannabis Stocks to Sell in July Before They Crash & Burn
Schwazze Announces Transition to OTC Expert Market and Provides Update on Delayed Filing
Schwazze Announces Grand Opening of its 35th New Mexico Dispensary in Bernalillo
Medicine Man Technologies, Inc. (SHWZ) Q1 2024 Earnings Call Transcript
Schwazze Announces First Quarter 2024 Financial Results
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
Medicine Man Technologies, Inc. (SHWZ) Q4 2023 Earnings Call Transcript
Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results
Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET
From Seed to Profit: The Top Cannabis Penny Stocks to Watch
Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer
Medicine Man Technologies, Inc. (SHWZ) Q3 2023 Earnings Call Transcript
Schwazze Announces Third Quarter 2023 Financial Results
Schwazze Sets Third Quarter 2023 Conference Call for November 14, 2023 at 5:00 p.m. ET
Schwazze Announces Launch of Standing Akimbo Hotspot, a New Store Within A Store Concept in Fort Collins